NAT DEFENSE MEDICAL CT innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	Taiwan	69
#2	United States	31
#3	New Zealand	3
#4	Republic of Korea	2
#5	Singapore	2
#6	WIPO (World Intellectual Property Organization)	2
#7	Canada	1
#8	Chile	1
#9	China	1
#10	EPO (European Patent Office)	1
#11	Israel	1
#12	Japan	1
#13	Mexico	1
#14	Malaysia	1
#15	Philippines	1

Patent filings per year

Similar Companies

WELLMARKER BIO CO LTD 95% similarity

AVALON PHARMACEUTICALS 94% similarity

UNIV HEBEI MEDICAL 92% similarity

ONCALIS AG 92% similarity

HARE JOSHUA M 91% similarity

TRASLATIONAL CANCER DRUGS PHARMA S L 91% similarity

UNIV BRANDEIS 91% similarity

ZILA BIOTECHNOLOGY INC 91% similarity

SUTTER WEST BAY HOSPITALS 90% similarity

CT DE RECH PUBLIC DE LA SANTE 90% similarity

Focus industries

#	Industry
#1	Pharmaceuticals
#2	Organic fine chemistry
#3	Biotechnology
#4	Measurement
#5	Environmental technology

Focus technologies

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Measuring microorganism processes
#4	Heterocyclic compounds
#5	Analysing materials
#6	Acyclic or carbocyclic compounds
#7	Microorganisms
#8	Sugars
#9	Climate change adaptation technologies
#10	Microbiology

Top inventors

#	Name	Total Patents
#1	Chen Ann	24
#2	Huang Hsu-Shan	12
#3	Huang Hsu Shan	10
#4	Chang Wen-Liang	8
#5	Hwa Kuo Yuan	8
#6	Lai Hung-Cheng	8
#7	Yao Chen Wen	7
#8	Chen Tsung-Chih	7
#9	Yen Chung-Yang	7
#10	Ka Shuk Man	7

Latest patents

Publication	Filing date	Title
US2016184298A1	2016-03-07	Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2b (ugt2b)
SG10201406318YA	2014-10-03	Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
NZ700644A	2014-10-02	Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
TW201610158A	2014-09-12	Hybridoma cell line producing monoclonal antibodies against the ricin, the monoclonal antibodies therefrom, and reagent and elisa kit comprising the same
TW201610159A	2014-09-12	Hybridoma cell line producing monoclonal antibodies against the bont/a, the monoclonal antibodies therefrom, and reagent and elisa kit comprising the same
TW201609051A	2014-09-01	Method for detecting cardiac status, method for monitoring cardiac status during exercise, and apparatus for monitoring cardiac status
US2014343116A1	2014-07-30	Cytochrome p450 2c9 inhibitors
US2015329515A1	2014-05-13	Composition and method for treating or preventing influenza virus infection
TW201542203A	2014-05-13	Composition and method for treating or preventing influenza virus infection
TW201540304A	2014-04-22	Use of hydroxycinnamaldehyde glycoside derivatives for manufacturing composition for treating glomerulonephritis
TW201540297A	2014-04-22	Use of osthole for manufacturing composition for treating focal segmental glomerulosclerosis
TWI488843B	2014-02-14	Novel thiochromeno[2,3-c]quinolin-12-one derivatives, manufacturing method and application thereof
US8927717B1	2014-02-14	Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
TW201527283A	2014-01-13	Novel indeno[1,2-c]quinolin-11-one derivatives, preparation method and applications thereof
US2015197492A1	2014-01-13	NOVEL INDENO[1,2-c]QUINOLIN-11-ONE DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF
TW201520553A	2013-11-22	A nucleic acid based lateral flow immunoassay for bacteria detection
TW201517922A	2013-11-12	Method for synthesizing fluorine-18 labeled serotonin transporter imaging agents
TW201514497A	2013-10-11	Sglt2 as biomarker for diagnosing chronic kidney disease and monitoring the disease status after treatment
TW201505676A	2013-08-09	A drip weight sensing device and the weight sensing module thereof
TW201504628A	2013-07-31	Detection of botulinum neurotoxin type a and kit thereof